News Briefing channel feed – Endpoints News

News Briefing channel feed

Big Pharma R&D is exiting China, but leaving a legacy; China's biotech execs couldn’t be happier

8 years ago

Spectrum shares spike on preliminary PhII cancer data; Clinipace names a new CEO

8 years ago

Ablynx sets up a $175M IPO; Blade bags second tranche; Gritstone inks delivery tech deal with Arbutus

8 years ago

Boston biotech recruits Sanofi’s US cancer research chief; Syndax in-licenses Allergan portfolio

8 years ago

Exelixis shares surge on positive liver cancer results; Ramaswamy’s Myovant banks $140M for PhIII

8 years ago

Lupin is prepping a $1B US deal spree; Protagonist raising $60M for trial work

8 years ago

Amgen’s Bradway elected PhRMA chair; Abingworth provides £13M A round to antiviral startup VirionHealth

8 years ago

Ultragenyx wins priority review for burosumab; Genfit raising €150M for PhIII NASH study

8 years ago

Amgen catches a break as FDA rejects Neulasta knockoff; Zafgen gets a new CEO as Hughes moves to top science job

8 years ago

AstraZeneca’s next big cancer drug linked to falsified preclinical data; Harmony raises $270M, nabs development rights to narcolepsy drug

8 years ago

Sanofi/Regeneron win a new trial on Praluent patents; BridgeBio bankrolls $30M biotech startup

8 years ago

Congress fires another salvo at Allergan’s Mohawk deal; AI outfit raises $60M for discovery effort

8 years ago

Hot on heels of a positive PhIII, Ablynx files $150M IPO; Shire sues Allergan over dry eye drug rivalry

8 years ago

Rigel surges as FDA waives panel; Troubled Endocyte looks for comeback following $12M licensing deal; Seattle Genetics scores a ‘breakthrough’

8 years ago

Biotech makes a $303M run on Wall Street; Billionaire Thiel backs a startup round for antibiotic developer

8 years ago

Focused on PhIII, BeiGene touts early PD-1 results; Amgen partners with Simcere on China biosimilars work

8 years ago

Mateon punts failed late-stage cancer drug, axes staffers; Medivir boosted by osteoarthritis data

8 years ago

Newly debuted biotech shoots for $40M IPO; Intellia touts new animal data on CRISPR/Cas9

8 years ago

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C

8 years ago

AbbVie partners on an Opdivo combo study with Bristol-Myers; Intercept tumbles on FDA warning

8 years ago

Sanofi, NIH create a three-pronged antibody to target HIV; Akari soars on PhIII plans; Juno plots planned $225M raise

8 years ago

Arcus scores $305M regional development pact with Taiho; Shire, Shionogi tout PhIII ADHD study

8 years ago

OptiNose files for $100M IPO; GSK wins three-in-one COPD OK

8 years ago

Avanir vet Keith Katkin takes charge at Urovant; Teva unloads assets while uploading new CEO

8 years ago

First page Previous page 65 66 676869 70 71 Next page Last page